About

Bowon Koh is an associate in the Tax Department. She works primarily in U.S. federal corporate, partnership and international tax matters and represents corporate, private…

Bowon Koh is an associate in the Tax Department. She works primarily in U.S. federal corporate, partnership and international tax matters and represents corporate, private equity and investment fund clients with inbound and outbound mergers and acquisitions, cross-border bank financing arrangements, debt restructurings, securities issuances, cross-border investments and REIT and other specialized real-estate transactions.

Matters representative of her work include acting for an international data service company in its cross-border restructuring, for a global biopharmaceutical company in mergers and acquisitions and for a multinational manufacturing company in its debt restructuring. She is also fluent in Korean and conversational in Turkish and Chinese.

Latest Post

On March 18, 2020, President Trump signed into law the Families First Coronavirus Response Act (“FFCRA”) (H.R. 6201), and on March 27, 2020, he signed into law the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) (H.R. 748). This alert summarizes certain loan and tax-related provisions of these new laws that are most relevant to nonprofit organizations.

About

Bowon Koh is an associate in the Tax Department. She works primarily in U.S. federal corporate, partnership and international tax matters and represents corporate, private…

Bowon Koh is an associate in the Tax Department. She works primarily in U.S. federal corporate, partnership and international tax matters and represents corporate, private equity and investment fund clients with inbound and outbound mergers and acquisitions, cross-border bank financing arrangements, debt restructurings, securities issuances, cross-border investments and REIT and other specialized real-estate transactions.

Matters representative of her work include acting for an international data service company in its cross-border restructuring, for a global biopharmaceutical company in mergers and acquisitions and for a multinational manufacturing company in its debt restructuring. She is also fluent in Korean and conversational in Turkish and Chinese.

Subscribe: Subscribe via RSS